Acadia Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 20.73M 342K 2025-06
ALKERMES USD 49.46M 263K 2025-06
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Corcept Therapeutics USD 3.43M 1.03M 2025-06
Cytokinetics 112.55M 12.71M 2025-06
Eisai JPY 42.6B 2B 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Incyte USD 78.77M 10.96M 2025-06
J&J USD 7.6B 304M 2025-06
Moderna USD 119M 29M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Prothena 970K 4.78M 2024-09
PTC Therapeutics USD 15.48M 2.62M 2025-06
Sarepta Therapeutics USD 153.22M 15.66M 2025-06
Ultragenyx Pharmaceutical USD 23M 5.66M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


Acadia Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.